News
First off, what is Peyronie’s disease? The condition is characterized by an abnormal curve or bend of the penis that is ...
AUSTIN, TX / ACCESS Newswire / June 25, 2025 / In 2025, your logo doesn’t represent the brand. Your face does. Consumers ...
Quantified, the AI role play platform that sales, commercial, training, and compliance teams rely on to practice, coach, and certify at scale, announced the release of the newest version of Compliance ...
If the FDA charged food companies user fees it could strengthen its oversight of food safety, according to a recent study. The study, “Advancing the FDA’s ...
As part of its chemicals in food program the FDA ensures exposure to chemicals is safe. This includes chemicals authorized for use in and with foods during food packaging, processing or other ...
Lawyer who once defended drug kingpin 'El Chapo' questions critics of her judicial victory - Newsday
Silvia Delgado, a former lawyer for drug lord Joaquín "El Chapo" Guzmán in 2016, receives her electoral certification document for winning a judgeship in the June 1 judicial elections, in Ciudad ...
The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s spread among people given an injection twice a year in clinical ...
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be ...
FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.
Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may ...
Trump’s pick to lead the FAA has portrayed himself as a certified commercial pilot. He isn’t.
FDA approval of pembrolizumab marks major shift in head and neck cancer treatment - News-Medical.net
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results